Rapid7's Q2 revenue, adj EPS beat analyst estimates
Rapid7's Q2 revenue, adj EPS beat analyst estimates
Overview
US cybersecurity operations provider's Q2 revenue declined 1.5% yr/yr but beat analyst expectations
Adjusted EPS for Q2 beat analyst expectations
Company initiated restructuring plan affecting about 12% of workforce
Outlook
Rapid7 sees Q3 revenue between $208 mln and $210 mln
Company expects full-year 2026 revenue between $837 mln and $841 mln
Rapid7 anticipates Q3 ARR of approximately $812 mln
Result Drivers
RESTRUCTURING PLAN - Co initiated restructuring to streamline operations and align resources with core platform solutions, affecting about 12% of workforce
Company press release: ID:nGNX1ck93d
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $210.88 mln | $208.25 mln (22 Analysts) |
Q2 Adjusted EPS | Beat | $0.44 | $0.35 (23 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 18 "hold" and 4 "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy."
Wall Street's median 12-month price target for Rapid7, Inc. is $8.00, about 30.9% below its August 7 closing price of $11.57
The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 4 three months ago
Reuters Recommended Reads
Aug 10 - N-Able Q2 revenue slightly beats estimates on AI-powered cybersecurity growth
Aug 10 - Latch Q2 software revenue rises on expanding platform adoption
Aug 10 - Monday.com Q2 revenue rises as AI focus grows
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Rapid7
See all newsBrief: Rapid7 Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
CrowdStrike sparks rally across cybersecurity stocks after upbeat forecast
Brief: Rapid7 Finds Nearly Two-Thirds Of Vulnerabilities Exploited In Q2 2026 Required No User Interaction To Initiate
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics